Advertisement

Reactions Weekly

, Volume 1730, Issue 1, pp 224–224 | Cite as

Nilotinib

Hepatotoxicity: case report
Case report
  • 11 Downloads

Reference

  1. Qi J, et al. Imatinib as Second-Line Treatment Drug for CML Patients Intolerant to Nilotinib. Zhongguo Shi Yan Xue Ye Xue Za Zhi 26: 407-411, No. 2, Apr 2018. Available from: URL: http://doi.org/10.7534/j.issn.1009-2137.2018.02.016 [Chinese; summarised from a translation] - China

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations